Position in VCYT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$61,421,360
+$34,826,369 QoQ
Shares Held
1,045,826
+65.6% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#18
of 367 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Driehaus Capital Management LLC holds $537,568,705 across 6 Diagnostics & Research names. VCYT ranks #4 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
1,533,985 | $230,143,769 | |
| 2 | TWST |
Twist Bioscience Corp
|
1,022,526 | $105,197,474 | |
| 3 | NTRA |
Natera, Inc.
|
383,872 | $104,202,054 | |
| 4 | VCYT |
Veracyte, Inc.
This page
|
1,045,826 | $61,421,360 | |
| 5 | NEO |
Neogenomics Inc
|
2,508,845 | $36,604,048 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
631,926 | $0 |
All Filings in VCYT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,421,360 | 1,045,826 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $26,594,991 | 631,710 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $40,068,120 | 1,351,370 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $46,877,133 | 1,183,766 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,329,696 | 362,212 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $11,249,664 | 408,930 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,227,537 | 413,235 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,548,935 | 414,171 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,905,817 | 399,364 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,708,773 | 409,135 | Shares | Sole | 2023-02-14 | |
| 2020-03-31 | $1,645,981 | 67,708 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||